Trials / Completed
CompletedNCT01371474
Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,483 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
The objective of this survey was to understand the safety and efficacy of PAXIL tablets ("PAXIL", hereinafter) when it was started at 20 mg/day in subjects with depression or in a depressed state.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paroxetine |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2008-03-01
- Completion
- 2008-06-01
- First posted
- 2011-06-10
- Last updated
- 2017-05-22
Source: ClinicalTrials.gov record NCT01371474. Inclusion in this directory is not an endorsement.